Goldman Sachs Group Inc Immuno Gen, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.46 - $29.95 $618,190 - $1.49 Million	-49,614 Reduced 4.0%	1,189,485 $35.3 Million
Q3 2023 May 14, 2024	BUY	$14.09 - $19.87 $699,061 - $985,830	49,614 Added 4.17%	1,239,099 $19.7 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $5.24 Million - $7.39 Million	-372,003 Reduced 23.09%	1,239,099 $19.7 Million
Q2 2023 May 14, 2024	SELL	$3.75 - $20.05 $2.26 Million - $12.1 Million	-602,717 Reduced 27.23%	1,611,102 $30.4 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $2.26 Million - $12.1 Million	-602,717 Reduced 27.23%	1,611,102 $30.4 Million
Q1 2023 May 14, 2024	SELL	$3.67 - $4.92 $1.58 Million - $2.11 Million	-429,450 Reduced 16.25%	2,213,819 $8.5 Million
Q1 2023 May 11, 2023	SELL	$3.67 - $4.92 $1.58 Million - $2.11 Million	-429,450 Reduced 16.25%	2,213,819 $8.5 Million
Q4 2022 May 14, 2024	BUY	$4.55 - $6.31 $7.18 Million - $9.96 Million	1,578,901 Added 148.34%	2,643,269 $13.1 Million
Q4 2022 Feb 13, 2023	BUY	$4.55 - $6.31 $7.18 Million - $9.96 Million	1,578,901 Added 148.34%	2,643,269 $13.1 Million
Q3 2022 May 14, 2024	BUY	$4.48 - $6.47 $973,275 - $1.41 Million	217,249 Added 25.65%	1,064,368 $5.09 Million
Q3 2022 Nov 10, 2022	BUY	$4.48 - $6.47 $973,275 - $1.41 Million	217,249 Added 25.65%	1,064,368 $5.09 Million
Q2 2022 May 14, 2024	SELL	$3.15 - $5.76 $1.08 Million - $1.97 Million	-342,366 Reduced 28.78%	847,119 $3.81 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $526,481 - $962,709	167,137 Added 24.58%	847,119 $3.81 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $1.41 Million - $2.48 Million	-331,505 Reduced 32.77%	679,982 $3.24 Million
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $1.37 Million - $2.17 Million	-289,023 Reduced 22.22%	1,011,487 $7.51 Million
Q3 2021 Nov 10, 2021	BUY	$5.02 - $6.59 $6.53 Million - $8.57 Million	1,300,510 New	1,300,510 $7.37 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account